Merit Medical Systems, Inc.
$69.79
▼
-0.78%
2026-04-21 08:12:00
www.merit.com
NMS: MMSI
Explore Merit Medical Systems, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$4.22 B
Current Price
$69.79
52W High / Low
$100.19 / $66.34
Stock P/E
32.83
Book Value
$26.66
Dividend Yield
—
ROCE
7.59%
ROE
8.67%
Face Value
—
EPS
$2.13
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
7,500
Beta
0.65
Debt / Equity
51.86
Current Ratio
4.34
Quick Ratio
2.95
Forward P/E
15.53
Price / Sales
2.69
Enterprise Value
$4.43 B
EV / EBITDA
13.98
EV / Revenue
2.92
Rating
Buy
Target Price
$101.18
EPS Forecast (FY)
—
Pros
- Balance sheet leverage appears manageable.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Capital efficiency is modest.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | The Cooper Companies, Inc. | $67.65 | 33.54 | $13.23 B | 0.02% | 6.05% | 4.87% | $89.83 / $61.78 | $42.87 |
| 2. | Embecta Corp. | $9.6 | 4.08 | $568.51 M | 6.25% | 35.74% | -13.73% | $15.55 / $8.47 | $-10.35 |
| 3. | Teleflex Incorporated | $131.95 | — | $5.84 B | 1.03% | 4.14% | 1.58% | $138.93 / $100.18 | $70.7 |
| 4. | Bionano Genomics, Inc. | $1.31 | — | $14.53 M | — | -65.83% | -66.15% | $5.5 / $1.06 | $4.14 |
| 5. | Azenta, Inc. | $26.4 | — | $1.22 B | — | -1.19% | 1.53% | $41.73 / $19.87 | $37.26 |
| 6. | Precision Optics Corporation, Inc. | $4.44 | — | $47.43 M | — | -40.7% | -73.56% | $6.04 / $3.55 | $1.21 |
| 7. | Microbot Medical Inc. | $2.3 | — | $154.46 M | — | -18.87% | -32.42% | $4.67 / $1.6 | $1.16 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 393.94 M | 384.16 M | 382.46 M | 355.35 M | 355.16 M | — |
| Operating Profit | 53.98 M | 42.64 M | 47.02 M | 42.06 M | 36.72 M | — |
| Net Profit | 38.01 M | 27.75 M | 32.58 M | 30.15 M | 27.95 M | — |
| EPS in Rs | 0.64 | 0.47 | 0.55 | 0.51 | 0.47 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 1.52 B | 1.36 B | 1.26 B | 1.15 B |
| Operating Profit | 185.7 M | 156.14 M | 127.47 M | 101.06 M |
| Net Profit | 128.49 M | 120.36 M | 94.41 M | 74.52 M |
| EPS in Rs | 2.15 | 2.02 | 1.58 | 1.25 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 2.69 B | 2.42 B | 2.33 B | 1.66 B |
| Total Liabilities | 1.1 B | 1.04 B | 1.12 B | 519.57 M |
| Equity | 1.58 B | 1.38 B | 1.2 B | 1.14 B |
| Current Assets | 1.04 B | 923.77 M | 1.11 B | 529.08 M |
| Current Liabilities | 239.76 M | 216.4 M | 203.56 M | 220.65 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 297.37 M | 220.8 M | 145.15 M | 114.29 M |
| Investing CF | -247.39 M | -368.65 M | -175.35 M | -57.4 M |
| Financing CF | 16 M | -60.01 M | 559.27 M | -60.26 M |
| Free CF | 212.53 M | 182.76 M | 108.45 M | 66.09 M |
| Capex | -84.84 M | -38.04 M | -36.7 M | -48.2 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 7.89% | 9.24% | — | — |
| Earnings Growth % | 27.48% | 26.7% | — | — |
| Profit Margin % | 8.87% | 7.51% | 6.47% | — |
| Operating Margin % | 11.51% | 10.14% | 8.78% | — |
| Gross Margin % | 47.43% | 46.44% | 45.1% | — |
| EBITDA Margin % | 21.82% | 18.2% | 15.74% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.